ANGLE plc (AIM: AGL)

Market Cap	37.90M
Revenue (ttm)	2.19M
Net Income (ttm)	-20.13M
Shares Out	322.53M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,200,840
Open	11.61
Previous Close	11.75
Day's Range	11.07 - 11.74
52-Week Range	9.07 - 37.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 26, 2024

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with high analytical sensitivity and specificity for the identification, characterization, and enumera...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1994
• Employees: 150
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AGL

Financial Performance

In 2023, ANGLE's revenue was 2.19 million, an increase of 109.99% compared to the previous year's 1.04 million. Losses were -20.13 million, -7.17% less than in 2022.